A detailed history of Gem Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gem Asset Management, LLC holds 3,963 shares of ABT stock, worth $462,878. This represents 0.26% of its overall portfolio holdings.

Number of Shares
3,963
Previous 3,762 5.34%
Holding current value
$462,878
Previous $391 Million 14.92%
% of portfolio
0.26%
Previous 0.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$100.07 - $118.13 $20,114 - $23,744
201 Added 5.34%
3,963 $449 Million
Q2 2024

Aug 07, 2024

BUY
$100.73 - $112.44 $15,109 - $16,866
150 Added 4.15%
3,762 $391 Million
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $2,615 - $3,078
-27 Reduced 0.74%
3,612 $366 Million
Q4 2022

Jan 30, 2023

BUY
$95.06 - $111.52 $345,923 - $405,821
3,639 New
3,639 $400 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gem Asset Management, LLC Portfolio

Follow Gem Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gem Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gem Asset Management, LLC with notifications on news.